View of Progression-free survival as a surrogate endpoint for overall survival in antibody-drug conjugate trials for advanced breast cancer: a systematic review and meta-analysis

Return to Article Details Progression-free survival as a surrogate endpoint for overall survival in antibody-drug conjugate trials for advanced breast cancer: a systematic review and meta-analysis Download Download PDF